Source https://www.fightaging.org/archives/2022/10/alzheimers-disease-as-innate-autoimmunity/
The failure of amyloid-β clearance via immunotherapy to produce benefits in Alzheimer’s disease patients has spurred a great deal of theorizing, attempts to find a new way forward. Most researchers, from a survey of the field, continue to believe that amyloid-β aggregation is an important contributing factor in at least the early development of Alzheimer’s. However, an increasing emphasis on immune dysfunction and chronic inflammation is creeping into modified versions of the <a href="https://en.wikipedia.org/wiki/Biochemi…
Source https://www.fightaging.org/archives/2022/10/alzheimers-disease-as-innate-autoimmunity/
The failure of amyloid-β clearance via immunotherapy to produce benefits in Alzheimer’s disease patients has spurred a great deal of theorizing, attempts to find a new way forward. Most researchers, from a survey of the field, continue to believe that amyloid-β aggregation is an important contributing factor in at least the early development of Alzheimer’s. However, an increasing emphasis on immune dysfunction and chronic inflammation is creeping into modified versions of the <a href="https://en.wikipedia.org/wiki/Biochemi…
What Do You Think?
comments